New Quality Forces New Growth Unleashed

BIOLIGN Conference Guangzhou 2026

May 19-20 | Guangzhou, China

One of the most expected pharmaceutical
industry events in the Greater Bay Area

Organizer

Supporter of BIOLIGN

Official Partners of BIOLIGN

BIOLIGN CONFERENCE

The BIOLIGN Conference Guangzhou 2026 is dedicated to providing a high-level communication and exhibition platform for local/international pharmaceutical companies, Biotech firms, CRO/CDMO/ CMO, investment institutions, synthetic biology technology companies, single-cell and multiomics research institutions, instrument/equipment/reagent suppliers, technology/software/ service providers, law firms/consulting agencies, as well as parks, governments, research institutes, and universities. Leaders in the innovation ecosystem will gather at the conference to condense opinions, refine consensus and gain insights into cutting-edge trends and technological innovations in the pharmaceutical industry, which is to explore an innovative progress path to industrial cooperation of biomedicine.

Click here for post-event highlights and live coverage of BIOLIGN Thousand-people Assembly in South China！

Download Post-event Report of South China Conference

BIOLIGN 2026@Guangzhou

5000+

ATTENDEES

200+

SPEAKERS

1000+

B2B MATCHMAKING

100+

SPONSORS

New Quality Forces New Growth Unleashed

Part of Previous Speakers

Daiming Fan

Academician
The Chinese Academy
of Sciences

Zhigang Tian

Academician
The Chinese Academy
of Engineering

Dawei Ma

Academician
The Chinese Academy
of Sciences

Hongzhou Lu

AAM Fellow
Dean of The Third People's
Hospital of Shenzhen

Jinhui Li

General Manager of
Hospital's Emergency BU
Pfizer China

Jiang Qian

GM of China
BMS

Zhigang Sun

VP, CQO
Hengrui Pharmaceuticals

Yutian Wang

Academician
Royal Society of
Canada

Jens Ewert

Life Sciences &
Health Care Leader
Deloitte China

Tony Guo

VP and Global Head of
Statistics and Data Sceince
BeOne

Mingxiu Hu

SVP
Akeso

Xueqing Yu

Dean
Guangdong Provincial
People's Hospital

Kaisheng Huang

CQO
RemeGen Co., Ltd.

Linna Wang

CMO at Chia Tai
Innovation R&D Center
China Biopharma

CMO

Dongzhou Liu

CSO & President of
Global Development
Huadong Medicine

Ling Yang

VP
CTTQ PHARMA

Aimin Hui

General Manager
SharpSight Biopharma
Consulting

Wenzhi Tian

Chairman and GM
ImmuneOnco

Lun Zeng

VP
Xiangxue Pharmaceutical

Yongzeng Wang

CTO
Juventas

Gang Qin

CEO/Founder/Chairman
GeneQuantum
Healthcare

Ruhong Jiang

CEO
ASC Therapeutics

陈Gong Chen功

Founder
NeuExcell
Therapeutics

Fubing Li

Co-Founder/CSO
Constimulus

Wenji Dong

Founder&CEO
Genmedicn Biopharma

Jiaqiang Cai

Co-founder&CSO
MediLink Therapeutics

Wenjun Zhang

CEO
ExcelMab

Penghui Zhou

Founder
Fanen Biotechnology

Dan Liu

Managing Partner
China Region
Pivotal bioVenture Partners

Bo Liu

Managing Director
CDIB Capital

Quan Fu

Partner
Everest Venture

Jin Han

General Manager
Tasly Pharmaceutical

Cheng Zhang

SVP & CSO
Gmax Biopharm LLC

Jiong Lan

Founder&CEO
GenFleet Therapeutics

Minmin SUN

Founder & Chairman
&CEO

Immunofoco

Lei Fang

VP
Lepu Biopharma

Zhong Liu

VP
Lunan Pharmaceutical
Group

Hugh Davis

COO&President of
U.S. Branch Biosion

Li Chen

Founder and
CEO,CSO

Hua Medicine

Qiusong Tang

Head, Roche China
Accelartor
Roche

Xumu Zhang

RAE Foreign
Member

Xiaoyan Kang

Executive VPof Clinical
Development Center
& CMO (Oncology)
Qilu Pharmaceutical

James Yan

Chief Operating
Officer, R&D
Zai Lab Limited

Zhenwei Miao

Chairman & Founder
iMBioRay

Wei Chen

Vice President of R&D
Gan & Lee Pharmaceuticals

Zhenping Wu

SVP
HUTCHMED

Ling Yang

Founder
Chairman & CEO
PersonGen

Hena Shi

VP & GM of Oncology
Division
Betta Pharmaceuticals

Yanhong Deng

deputy superintendent
The Sixth Affiliated Hospital
of Sun Yat-sen University

Shaojing Hu

Chairman&CEO
3H Pharmaceuticals

Weimin Liu

Managing Director, Innovation
Center Investments
BeOne

Yun Qin

CMO
TCRCure

Qingzhen Yu

Business Partner
GTJA Investment
Group

Pandy Song

Partner
Northern Light
Venture Capital

Xuanhui Xie

Chief Innovation &
Investment Officer
IASO BIO

Shuhang Wang

Assoc. Chief Physician, GCP Center
Cancer Hospital Chinese Academy
of Medical Sciences

Robert Zhao

General Manager
DAC Biotech

Juncheng Wen

CMO
Poly Pharma

Weide Zhong

Chief Physician
Guangzhou First
People's Hospital

Xuejun Liang

Chairman & CEO
NovoCodex

Chunlai Cao

General Manager
The United Laboratories

International Holdings Ltd

Hongyun Zhao

Deputy Director
Sun Yat-sen University
Cancer Center

Qinru Liang

CSO
HEC CJ PHARM

Peng Lin

Deputy General Manager
China Resources Biomedical

Yuanjia Hu

Director, Drug Regulation
Center
University of Macau

Jinzhong Chen

VP
Luye Life Sciences

Zhongfang Wang

Researcher
Guangzhou Laboratory

Furong Li

Associate Dean
SUSTech Health Institute

Yonghong Hi

Deputy General Manager
CorreGene

Hingyu Zhu

Chief Business Strategy
& Development Officer
GeneQuantum

Chang Bai

Co-CEO &CSO
IONOVA LIFE

Yandong Zhang

General Manager
CSO
KEYE LIFE

Qun Dang

President
Genuine Biotech

Tinke Tang

General Manager
Business Development
Livzon Pharmaceutical

Linping Wu

Researcher
GIBH

Jiasheng Xie

Executive President
GDMV

Jin Fan

Founder/CEO
Hopstem Biotechnology

Yang Hu

CEO
Lumiere Therapeutic

Yihan Wang

Founder, Chairman
& CEO
TargetRx

Jiancun Zhang

ChairmanHenovcom
Bioscience

Binhe Tan

Partner & VP
Manufacturing & CMC
BRL Medicine

Xianfeng Lu

Deputy
General Manager
InnoCare

Jianxin Duan

Chairman & General
Manager
Ascentawits

Ping Zhou

Chairman
Wuhan Yinuo Pharmaceutical

Meng Yu

Deputy General Manager
China & Executive Director
HighTide

Chenguang Yuan

Co-Founder & CSO
Sungening Bio-Medical

Xiaoping Chen

Founder & CSO
CAS Lamvac Biotech

Shubin Wang

Director, Department of Oncology
Peking University
Shenzhen Hospital

Tao Xu

Director, R&D Center,
Tsinghua Shenzhen
Research Institute

Haitao Li

CTO
Rigerna Therapeutics

Yuqiang Wang

CEO
Magpie Pharmaceuticals

陈华林

Hualin Chen
Chief Physician
Pulmonary Oncology
Affiliated Hospital of
GDMU

Jiayin Yang

Co-Founder
CTO
Cell Inspire

Jinjing Zhang

Partner
WestGene

Su Wu

irector, Innovative
Drug Research Center
GBA-IPM

Chen Chen

CBO
Micot

In Alphabetical Order
Job Titles Align with the Newest Information

Part of Collaborative Partners

Part of Media Partners

Industry Insights – Empowering Innovations

Selected Product & Technical White Papers

Selected Research Report from Consultancies

Exclusive Interviews of Executives and Experts

Spectacle of Previous Conferences

Formats of BIOLIGN 2026

To Be Sponsors

Efficient 1-on-1 business matchmaking on-site, accurately reaching potential target customers Opportunities for deep involvement in the main forum, sub-forums, and roundtables, fully showcasing industry leadership Exclusive opportunities for on-site tea breaks, badge sponsorship, etc., to enhance brand visibility Unique customized programs that align with promotional goals, enjoying high exposure online and offline before, during, and after the conference

To Be Exhibitor

Efficient 1-on-1 business matchmaking on-site, accurately reaching potential target customers Limited exhibition slots in specific fields, gathering industry attention and directing potential clients to exclusive exhibition areas Get a conference VIP pass for full access to the keynote session, sub-forums, and roundtables, to grasp the latest industry trends

To Be Attendee

Get a conference VIP pass for full access to keynote session, sub-forums, and 8 roundtables, to grasp the latest industry trends.Opportunity to interact and exchange opinions with decision-makers and experts from leading pharmaceutical and biotech companies on-site

To Be Speaker

Exclusive speaking opportunity to showcase solutions and project progress, and share professional knowledge, experience, and insights.Opportunity to interact and exchange perspectives with decision-makers and experts from leading pharmaceutical and biotech companies on-site. Speakers’ names and profiles will be included in the conference brochure

BIOLIGN

Dedicating to providing world-class platform for high-quality communication and collaboration，BIOLIGN is the leading brand of commercial events and community in the pharmaceutical industry, which covers the areas such as biopharmaceuticals, small molecule innovation drugs, synthetic biology, precision medicine. BIOLIGN conference will address the latest industry hotspots and trends, emphasize nextgeneration innovative therapies and disruptive new technologies, and bring together industry leaders and elites to discuss openly about future strategies that can inspire innovation, upgrades and transformation of pharmaceutical industry.

It consistently adheres to the 3C philosophy, namely Creativity, Connection and Changes, and is committed to promoting industry momentum and resource integration to maximize commercial value.

Register

Contact us

Phone： 0086-20-89305001

Email： lbz@epochsgroup.com

Website： biolign.lbzepochs.com

Customer service：

WeChat QR code：